Intrinsic Value of S&P & Nasdaq Contact Us

Masimo Corporation MASI NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
50/100
4/7 Pass
SharesGrow Intrinsic Value
$80.47
-54.9%
Analyst Price Target
$187.50
+5.1%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Masimo Corporation (MASI) has a negative trailing P/E of -63.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 32.4 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -1.58%, forward earnings yield 3.08%. PEG 4.16.

Criteria proven by this page:

  • VALUE (60/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Forward P/E 32.4 — analysts expect a return to profitability with estimated EPS of $5.50 for FY2026.
  • PEG Ratio 4.16 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield -1.58% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 3.08% as earnings recover.
  • Analyst consensus target $187.50 (+5.1% upside) — modest upside expected.

Overall SharesGrow Score: 50/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
50/100
SG Score
View full scorecard →
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
FUTURE
61/100
Analyst consensus
→ Forecast
~
PAST
50/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
MOAT
74/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — MASI

Valuation Multiples
P/E (TTM)-63.1
Forward P/E32.4
PEG Ratio4.16
Forward PEG4.16
P/B Ratio13.26
P/S Ratio6.28
EV/EBITDA29.0
Per Share Data
EPS (TTM)$-2.83
Forward EPS (Est.)$5.50
Book Value / Share$13.46
Revenue / Share$28.49
FCF / Share$3.65
Yields & Fair Value
Earnings Yield-1.58%
Forward Earnings Yield3.08%
Dividend Yield0.00%
SharesGrow IV$80.47 (-54.9%)
Analyst Target$187.50 (+5.1%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 11.1 0.04 5.96 4.68 -
2017 33.2 -0.54 6.03 5.53 -
2018 31.1 0.73 6.21 7.01 -
2019 43.0 6.75 7.23 9.01 -
2020 61.1 3.11 10.43 12.84 -
2021 70.3 -13.43 10.42 13.03 -
2022 55.3 -1.55 5.92 3.90 -
2023 75.9 -1.79 4.53 3.02 -
2024 -29.9 0.06 8.66 4.35 -
2026 -45.1 0.89 9.47 4.47 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $5.85 $694.63M $300.67M 43.3%
2017 $2.23 $798.11M $131.62M 16.5%
2018 $3.45 $858.29M $193.54M 22.5%
2019 $3.44 $937.84M $196.22M 20.9%
2020 $4.14 $1.14B $240.3M 21%
2021 $3.98 $1.24B $229.6M 18.5%
2022 $2.60 $2.04B $143.5M 7%
2023 $1.51 $2.05B $81.5M 4%
2024 $-5.72 $2.09B $-304.9M -14.6%
2025 $-2.80 $1.53B $-151.5M -9.9%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $5.50 $5.45 – $5.53 $1.52B $1.51B – $1.53B 5
2027 $5.91 $5.49 – $6.14 $1.62B $1.62B – $1.63B 2
2028 $6.64 $6.13 – $7.02 $1.75B $1.74B – $1.76B 5
2029 $7.43 $7.39 – $7.48 $1.89B $1.87B – $1.91B 1
2030 $7.43 $7.39 – $7.48 $1.97B $1.97B – $1.98B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message